PP_1170x120_10-25-21

Scott Richards

Mayne Pharma releases Bupap generic

Mayne Pharma releases Bupap generic

GREENVILLE, N.C. — Mayne Pharma Inc. has launched butalbital acetaminophen tablets 50 mg/300 mg, a migraine medication, in the United States. Mayne said Thursday that it will distribute the product, a generic version of Bupap tablets (butalbital acetaminophen 50 mg/300 mg) from Valeant Pharmaceuticals International, on behalf of its partner Mikart Inc., the developer and

Mayne Pharma releases Fabior, Sorilux foam

Mayne Pharma releases Fabior, Sorilux foam

GREENVILLE, N.C. — Mayne Pharma Inc. has rolled out Fabior Foam 0.1%, an acne treatment, and Sorilux Foam 0.005%, a psoriasis treatment, in the United States. Launched by the Mayne Pharma Specialty Brands division, Fabior and Sorilux foam previously were marketed by GlaxoSmithKline. Mayne acquired the two products in August 2016. Mayne said Fabior and